Show simple item record

dc.contributor.authorJiang, X
dc.contributor.authorEales, JM
dc.contributor.authorScannali, D
dc.contributor.authorNazgiewicz, A
dc.contributor.authorPrestes, P
dc.contributor.authorMaier, M
dc.contributor.authorDenniff, M
dc.contributor.authorXu, X
dc.contributor.authorSaluja, S
dc.contributor.authorCano-Gamez, E
dc.contributor.authorWystrychowski, W
dc.contributor.authorSzulinska, M
dc.contributor.authorAntczak, A
dc.contributor.authorByars, S
dc.contributor.authorSkrypnik, D
dc.contributor.authorGlyda, M
dc.contributor.authorKrol, R
dc.contributor.authorZywiec, J
dc.contributor.authorZukowska-Szczechowska, E
dc.contributor.authorBurrell, LM
dc.contributor.authorWoolf, AS
dc.contributor.authorGreenstein, A
dc.contributor.authorBogdanski, P
dc.contributor.authorKeavney, B
dc.contributor.authorMorris, AP
dc.contributor.authorHeagerty, A
dc.contributor.authorWilliams, B
dc.contributor.authorHarrap, SB
dc.contributor.authorTrynka, G
dc.contributor.authorSamani, NJ
dc.contributor.authorGuzik, TJ
dc.contributor.authorCharchar, FJ
dc.contributor.authorTomaszewski, M
dc.date.accessioned2020-12-09T22:38:18Z
dc.date.available2020-12-09T22:38:18Z
dc.date.issued2020-12-21
dc.identifierpii: 5940440
dc.identifier.citationJiang, X., Eales, J. M., Scannali, D., Nazgiewicz, A., Prestes, P., Maier, M., Denniff, M., Xu, X., Saluja, S., Cano-Gamez, E., Wystrychowski, W., Szulinska, M., Antczak, A., Byars, S., Skrypnik, D., Glyda, M., Krol, R., Zywiec, J., Zukowska-Szczechowska, E. ,... Tomaszewski, M. (2020). Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney. EUROPEAN HEART JOURNAL, 41 (48), pp.4580-4588. https://doi.org/10.1093/eurheartj/ehaa794.
dc.identifier.issn0195-668X
dc.identifier.urihttp://hdl.handle.net/11343/253026
dc.description.abstractAIMS: Angiotensin-converting enzyme 2 (ACE2) is the cellular entry point for severe acute respiratory syndrome coronavirus (SARS-CoV-2)-the cause of coronavirus disease 2019 (COVID-19). However, the effect of renin-angiotensin system (RAS)-inhibition on ACE2 expression in human tissues of key relevance to blood pressure regulation and COVID-19 infection has not previously been reported. METHODS AND RESULTS: We examined how hypertension, its major metabolic co-phenotypes, and antihypertensive medications relate to ACE2 renal expression using information from up to 436 patients whose kidney transcriptomes were characterized by RNA-sequencing. We further validated some of the key observations in other human tissues and/or a controlled experimental model. Our data reveal increasing expression of ACE2 with age in both human lungs and the kidney. We show no association between renal expression of ACE2 and either hypertension or common types of RAS inhibiting drugs. We demonstrate that renal abundance of ACE2 is positively associated with a biochemical index of kidney function and show a strong enrichment for genes responsible for kidney health and disease in ACE2 co-expression analysis. CONCLUSION: Our results indicate that neither hypertension nor antihypertensive treatment is likely to alter the expression of the key entry receptor for SARS-CoV-2 in the human kidney. Our data further suggest that in the absence of SARS-CoV-2 infection, kidney ACE2 is most likely nephro-protective but the age-related increase in its expression within lungs and kidneys may be relevant to the risk of SARS-CoV-2 infection.
dc.languageEnglish
dc.publisherOXFORD UNIV PRESS
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleHypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney
dc.typeJournal Article
dc.identifier.doi10.1093/eurheartj/ehaa794
melbourne.affiliation.departmentAnatomy and Neuroscience
melbourne.affiliation.departmentPhysiology
melbourne.affiliation.departmentClinical Pathology
melbourne.affiliation.departmentMedicine (Austin & Northern Health)
melbourne.affiliation.facultyMedicine, Dentistry & Health Sciences
melbourne.source.titleEuropean Heart Journal
melbourne.source.volume41
melbourne.source.issue48
melbourne.source.pages4580-4588
melbourne.identifier.nhmrc1104686
dc.rights.licenseCC BY
melbourne.elementsid1480436
melbourne.openaccess.pmchttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665509
melbourne.contributor.authorCharchar, Fadi
melbourne.contributor.authorBurrell, Louise
melbourne.contributor.authorHarrap, Stephen
melbourne.contributor.authorByars, Sean
dc.identifier.eissn1522-9645
melbourne.identifier.fundernameidNHMRC, 1104686
melbourne.accessrightsOpen Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record